Literature DB >> 30363411

The Presence of Alpha-Synuclein in Skin from Melanoma and Patients with Parkinson's Disease.

Ildefonso Rodriguez-Leyva1, Erika Chi-Ahumada2, Manuel Mejía2, Juan P Castanedo-Cazares3, William Eng4, Sami K Saikaly4, Juan Carrizales2, Todd D Levine5, Robert A Norman4, Maria E Jimenez-Capdeville2.   

Abstract

BACKGROUND: The misfolding and prion-like propagation of the protein α-synuclein (α-syn) is the leading molecular signature in Parkinson's disease (PD). There is a significant coincidence of PD and melanoma that may suggest a shared pathophysiology. This study compared the presence of α-syn in neural crest-derived tissues, such as nevi, melanoma, skin tags, and skin biopsies from patients with PD and healthy controls.
METHODS: Biopsies from participants with PD were obtained from patients from a tertiary referral center for dermatology and neurology in Mexico and a private dermatopathology center in Florida between January 2015 and March 2016. Biopsies from 7 patients with melanoma, 15 with nevi, 9 with skin tags, 8 with PD, and 9 skin biopsies from healthy volunteers were analyzed for immunohistochemical determination of α-syn and tyrosinase. All analyses were performed by pathologists who were blinded with respect to the clinical diagnosis.
RESULTS: In healthy controls, positive α-syn status was restricted to scattered cells in the basal layer of the epidermis and accounted for 1 ± 0.8% of the analyzed area. In patients with PD, there was increased staining for α-syn PD (3.3 ± 2.3%), with a higher percentage of positive cells in nevi (7.7 ± 5.5%) and melanoma (13.6 ± 3.5%). There was no increased staining in skin tags compared with healthy controls.
CONCLUSION: Patients with PD and melanoma have increased staining for α-syn in their skin. The authors propose that neurons and melanocytes, both derived from neuroectodermal cells, may share protein synthesis and regulation pathways that become dysfunctional in PD and melanoma.

Entities:  

Keywords:  Parkinson disease; melanoma; proteinopathies; α‐synuclein

Year:  2017        PMID: 30363411      PMCID: PMC6174388          DOI: 10.1002/mdc3.12494

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  35 in total

1.  Parkinson disease and malignant melanoma in first-degree relatives of patients with early-onset melanoma.

Authors:  Jørgen H Olsen; Thomas L Jørgensen; Kathrine Rugbjerg; Søren Friis
Journal:  Epidemiology       Date:  2011-01       Impact factor: 4.822

2.  Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

Authors:  Glenda M Halliday; Anita Ophof; Melissa Broe; Poul H Jensen; Emma Kettle; Heidi Fedorow; Michael I Cartwright; Francine M Griffiths; Claire E Shepherd; Kay L Double
Journal:  Brain       Date:  2005-07-06       Impact factor: 13.501

Review 3.  A Review of the Association Between Parkinson Disease and Malignant Melanoma.

Authors:  Max Disse; Hilary Reich; Peter K Lee; Sarah S Schram
Journal:  Dermatol Surg       Date:  2016-02       Impact factor: 3.398

Review 4.  Melanin and neuromelanin binding of drugs and chemicals: toxicological implications.

Authors:  Oskar Karlsson; Nils Gunnar Lindquist
Journal:  Arch Toxicol       Date:  2016-06-16       Impact factor: 5.153

5.  Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on α-synuclein.

Authors:  Nripesh Dhungel; Simona Eleuteri; Ling-Bo Li; Nicholas J Kramer; Justin W Chartron; Brian Spencer; Kori Kosberg; Jerel Adam Fields; Klodjan Stafa; Anthony Adame; Hilal Lashuel; Judith Frydman; Kang Shen; Eliezer Masliah; Aaron D Gitler
Journal:  Neuron       Date:  2014-12-18       Impact factor: 17.173

Review 6.  The role of AKT/mTOR pathway in stress response to UV-irradiation: implication in skin carcinogenesis by regulation of apoptosis, autophagy and senescence.

Authors:  Elwira Strozyk; Dagmar Kulms
Journal:  Int J Mol Sci       Date:  2013-07-24       Impact factor: 5.923

7.  α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism.

Authors:  Ildefonso Rodríguez-Leyva; Ana Laura Calderón-Garcidueñas; María E Jiménez-Capdeville; Ana Arely Rentería-Palomo; Héctor Gerardo Hernandez-Rodriguez; Rodrigo Valdés-Rodríguez; Cornelia Fuentes-Ahumada; Bertha Torres-Álvarez; Julio Sepúlveda-Saavedra; Adolfo Soto-Domínguez; Martha E Santoyo; José Ildefonso Rodriguez-Moreno; Juan Pablo Castanedo-Cázares
Journal:  Ann Clin Transl Neurol       Date:  2014-07-01       Impact factor: 4.511

8.  Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice.

Authors:  Francisco Pan-Montojo; Oleg Anichtchik; Yanina Dening; Lilla Knels; Stefan Pursche; Roland Jung; Sandra Jackson; Gabriele Gille; Maria Grazia Spillantini; Heinz Reichmann; Richard H W Funk
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

9.  Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice.

Authors:  Francisco Pan-Montojo; Mathias Schwarz; Clemens Winkler; Mike Arnhold; Gregory A O'Sullivan; Arun Pal; Jonas Said; Giovanni Marsico; Jean-Marc Verbavatz; Margarita Rodrigo-Angulo; Gabriele Gille; Richard H W Funk; Heinz Reichmann
Journal:  Sci Rep       Date:  2012-11-30       Impact factor: 4.379

Review 10.  Signaling Pathways in Melanogenesis.

Authors:  Stacey A N D'Mello; Graeme J Finlay; Bruce C Baguley; Marjan E Askarian-Amiri
Journal:  Int J Mol Sci       Date:  2016-07-15       Impact factor: 5.923

View more
  9 in total

1.  Alpha-Synuclein and Its Role in Melanocytes.

Authors:  Nicole Rachinger; Nora Mittag; Ines Böhme-Schäfer; Wei Xiang; Silke Kuphal; Anja K Bosserhoff
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

2.  Blinded RT-QuIC Analysis of α-Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients.

Authors:  Sireesha Manne; Naveen Kondru; Huajun Jin; Geidy E Serrano; Vellareddy Anantharam; Arthi Kanthasamy; Charles H Adler; Thomas G Beach; Anumantha G Kanthasamy
Journal:  Mov Disord       Date:  2020-09-22       Impact factor: 10.338

Review 3.  Linking Parkinson's Disease and Melanoma: Interplay Between α-Synuclein and Pmel17 Amyloid Formation.

Authors:  Dexter N Dean; Jennifer C Lee
Journal:  Mov Disord       Date:  2021-05-22       Impact factor: 9.698

Review 4.  Regulation of Mitochondrial Dynamics in Parkinson's Disease-Is 2-Methoxyestradiol a Missing Piece?

Authors:  Paulina Bastian; Jaroslaw Dulski; Anna Roszmann; Dagmara Jacewicz; Alicja Kuban-Jankowska; Jaroslaw Slawek; Michal Wozniak; Magdalena Gorska-Ponikowska
Journal:  Antioxidants (Basel)       Date:  2021-02-06

5.  Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson's disease.

Authors:  Waijiao Cai; Pranay Srivastava; Danielle Feng; Yue Lin; Charles R Vanderburg; Yuehang Xu; Pamela Mclean; Matthew P Frosch; David E Fisher; Michael A Schwarzschild; Xiqun Chen
Journal:  Mol Neurodegener       Date:  2022-02-23       Impact factor: 14.195

6.  Association Between Parkinson's Disease and Melanoma: Putting the Pieces Together.

Authors:  Qing Ye; Ya Wen; Nasser Al-Kuwari; Xiqun Chen
Journal:  Front Aging Neurosci       Date:  2020-03-10       Impact factor: 5.750

Review 7.  Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease.

Authors:  Dominika Fricova; Jana Harsanyiova; Alzbeta Kralova Trancikova
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

8.  Occurrence of Total and Proteinase K-Resistant Alpha-Synuclein in Glioblastoma Cells Depends on mTOR Activity.

Authors:  Larisa Ryskalin; Rosangela Ferese; Gabriele Morucci; Francesca Biagioni; Carla L Busceti; Fabrizio Michetti; Paola Lenzi; Alessandro Frati; Francesco Fornai
Journal:  Cancers (Basel)       Date:  2022-03-08       Impact factor: 6.639

9.  Spreading of Alpha Synuclein from Glioblastoma Cells towards Astrocytes Correlates with Stem-like Properties.

Authors:  Larisa Ryskalin; Francesca Biagioni; Gabriele Morucci; Carla L Busceti; Alessandro Frati; Stefano Puglisi-Allegra; Michela Ferrucci; Francesco Fornai
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.